153 related articles for article (PubMed ID: 37878012)
1. Higher expression of programmed cell death 4 (PDCD4) in acute myeloid leukemia is associated with better prognosis after chemotherapy.
Tang H; Chen Y; Zhang N; Deng J; Zhou K
Ann Hematol; 2023 Dec; 102(12):3401-3412. PubMed ID: 37878012
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
[TBL] [Abstract][Full Text] [Related]
3. [Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients].
Xie W; Qian TT; Pang Y; Ye X; Huang WH; Zhu P; Fu L
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):934-938. PubMed ID: 33789374
[No Abstract] [Full Text] [Related]
4. High expression of AK1 predicts inferior prognosis in acute myeloid leukemia patients undergoing chemotherapy.
Qin T; Zhao H; Shao Y; Hu N; Shi J; Fu L; Zhang Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32519744
[TBL] [Abstract][Full Text] [Related]
5. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
6. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
7. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy.
Yang C; Shao T; Zhang H; Zhang N; Shi X; Liu X; Yao Y; Xu L; Zhu S; Cao J; Cheng H; Yan Z; Li Z; Niu M; Xu K
J Transl Med; 2018 Oct; 16(1):267. PubMed ID: 30285885
[TBL] [Abstract][Full Text] [Related]
8. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
[TBL] [Abstract][Full Text] [Related]
9. Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia.
Fleischmann M; Schnetzke U; Frietsch JJ; Sayer HG; Schrenk K; Hammersen J; Glaser A; Hilgendorf I; Hochhaus A; Scholl S
J Cancer Res Clin Oncol; 2022 Jun; 148(6):1481-1492. PubMed ID: 34297206
[TBL] [Abstract][Full Text] [Related]
10. High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia.
Liu Y; Lu R; Cui W; Pang Y; Liu C; Cui L; Qian T; Quan L; Dai Y; Jiao Y; Pan Y; Ye X; Shi J; Cheng Z; Fu L
Cancer Gene Ther; 2020 Feb; 27(1-2):38-44. PubMed ID: 30923336
[TBL] [Abstract][Full Text] [Related]
11. The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia.
Han C; He S; Wang R; Gao X; Wang H; Qiao J; Meng X; Li Y; Yu L
J Transl Med; 2021 Feb; 19(1):65. PubMed ID: 33579308
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
[TBL] [Abstract][Full Text] [Related]
13. High expression levels of SMAD3 and SMAD7 at diagnosis predict poor prognosis in acute myeloid leukemia patients undergoing chemotherapy.
Zhang J; Zhang L; Cui H; Zhang X; Zhang G; Yang X; Yang S; Zhang Z; Wang J; Hu K; Shi J; Ke X; Fu L
Cancer Gene Ther; 2019 May; 26(5-6):119-127. PubMed ID: 30177817
[TBL] [Abstract][Full Text] [Related]
14. [The Prognostic Value of FOSB Gene in Acute Myeloid Leukemia].
Luan SH; Ma YQ; Yang JJ; Wang H; Liu DH; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1063-1070. PubMed ID: 35981363
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the FUT family in acute myeloid leukemia.
Dai Y; Cheng Z; Pang Y; Jiao Y; Qian T; Quan L; Cui L; Liu Y; Si C; Chen J; Ye X; Chen J; Shi J; Wu D; Zhang X; Fu L
Cancer Gene Ther; 2020 Feb; 27(1-2):70-80. PubMed ID: 31209266
[TBL] [Abstract][Full Text] [Related]
16. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
[TBL] [Abstract][Full Text] [Related]
17. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric
Pollard JA; Guest E; Alonzo TA; Gerbing RB; Loken MR; Brodersen LE; Kolb EA; Aplenc R; Meshinchi S; Raimondi SC; Hirsch B; Gamis AS
J Clin Oncol; 2021 Oct; 39(28):3149-3160. PubMed ID: 34048275
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of Wnt and Fzd gene families in acute myeloid leukaemia.
Dai Y; Cheng Z; Fricke DR; Zhao H; Huang W; Zhong Q; Zhu P; Zhang W; Wu Z; Lin Q; Zhu H; Liu Y; Qian T; Fu L; Cui L; Zeng T
J Cell Mol Med; 2021 Feb; 25(3):1456-1467. PubMed ID: 33417298
[TBL] [Abstract][Full Text] [Related]
19. BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
Zhang J; Shi J; Zhang G; Zhang X; Yang X; Yang S; Wang J; Ke X; Fu L
Ann Hematol; 2018 Aug; 97(8):1391-1397. PubMed ID: 29696374
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]